| INTRODUCTION
The resident gut microbiota is essential for a number of host physiological processes. These include digestion of dietary factors, development of the gut immune system and resistance to colonisation by pathogens. 1 The human gut microbiome is made up predominately of four major bacterial phyla: Firmicutes, Bacteroidetes, Proteobacteria and Actinobacteria. 2, 3 Changes in, or imbalances of these are termed dysbiosis. Dysbiosis is linked to intestinal inflammation, 4 with a decrease in bacterial diversity, or richness, being the most consistent finding in relation to disease activity. 3, [5] [6] [7] Specifically, key changes have been identified in inflammatory bowel disease (IBD) such as a reduction in beneficial bacterial species including Faecalibacterium prausnitzii 8 and increases in more pathogenic species including members of Enterobacteriaceae. 9, 10 Furthermore, studies have shown that in patients with IBD, the microbiota is different from healthy controls longitudinally and across all IBD subtypes. 11 Currently it is not understood if dysbiosis is the cause of, or the result of, intestinal inflammation.
Inflammatory bowel disease can develop at any age but tends to occur in the majority of patients within the first two decades of life. 12, 13 It is difficult to assess changes in the microbiota prior to the development of IBD, as currently we are unable to predict those individuals who will develop the disease. To help understand the underlying aetiology of inflammation, it may therefore be beneficial to use a model to study the evolution of the microbiota over time.
Restorative proctocolectomy with ileal pouch-anal anastomosis is performed in patients with ulcerative colitis (UC) refractory to medical therapy. This approach is popular amongst patients, since it restores intestinal continuity and avoids the need for a permanent ileostomy. The ileoanal pouch is a potential model to study pathogenesis of inflammation as pouchitis is common; moreover 40% of those that develop pouchitis do so within 12 months. 14 The relatively short time from ileoanal pouch formation to inflammation allows the convenient longitudinal study of the microbiota which gives insight into potential patterns occurring both in disease and nondiseased states. Interestingly, inflammation within the ileoanal pouch is rarely seen in patients who have the same operation for familial adenomatous polyposis (FAP), 15, 16 thus raising the possibility that pouchitis shares a similar pathogenesis to the inflammation that is seen in UC. 17 The role of the microbiota has been suggested to contribute to the pathogenesis of pouchitis, 18 although its exact aetiology remains unclear. Novel laboratory techniques including next generation sequencing have transformed our understanding of the gut microbiota 19 although the exact bacterial taxonomical shifts in the ileoanal pouch have been difficult to interpret due to the heterogeneity in study designs, sampling techniques and analysis.
This systematic review will explore the literature on the microbiota of the ileoanal pouch both longitudinally and in health and disease.
2 | METHODS
| Types of studies
Randomised controlled trials, cohort studies and observational studies were included. Studies which reported duplicate results were excluded. Those where data could not be extracted were also excluded.
| Inclusion criteria
Studies were included if they reported microbiota analysis on either faecal samples or tissue from the ileoanal pouch, and provided information on specific bacterial taxa.
| Exclusion criteria
Studies were excluded if they did not report on patterns of individual bacterial taxa differences in the ileoanal pouch or if they reported on the microbiota of Crohn's disease or UC without any data on ileoanal pouch patients. We also excluded case reports and studies of fewer than ten patients. 
| Search methods for identification of studies

| Grading of studies
The GRADE system was used to assess quality of the studies. 20 Two independent reviewers (JPS and SO) assessed each study against GRADE standards and assigned a quality of evidence score of very low, low, moderate and high. Any disagreement was then solved by discussion and consensus.
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| RESULTS
The search strategy found 844 references that were imported for screening. Five duplicates were removed. We screened 839 studies against title and abstract and from this excluded 753 studies.
Eighty-six studies were assessed for full-text eligibility. Of these, 61 studies were excluded; 39 because of study design that did not fulfil the inclusion criteria (20 were review articles, 19 were abstracts containing less than 10 subjects), 20 did not report the required outcomes (10 did not report on individual taxa, three reported on bacterial metabolites, three reported on genetic changes, two described endoscopic outcomes, one reported immunological changes and one described tissue sampling techniques), one did not address the required patient population and one was not in English. After full screening, 25 studies were included. Manual reference searching identified a further paper, meaning there was a total of 26 papers included in the analysis (Figure 1 ).
| Microbiota pre-pouch formation vs pouch
There were reported differences in the microbiota prior to undergoing the first stage of an ileoanal pouch operation (colectomy) between UC patients and FAP patients with lower bacterial diversity seen in mucosal samples in the colon prior to colectomy in UC patients compared with FAP patients. 21 Smith et al 22 compared faeces from ileostomies in patients with UC and FAP prior to ileostomy closure and found there were significantly lower levels of Clostridium perfringens detected in the UC group. 22 As colonic bacteria are predominately anaerobic, it would be expected that anaerobic bacteria would be present in patients prior to colectomy.
Various studies have supported this highlighting that anaerobes mostly predominate in faecal samples pre-colectomy. 23 Specifically, Almeida et al 24 found that Veillonella was the most prevalent bacterial species in mucus from the terminal ileum, colonic segments and rectum 24 from patients with UC. The authors suggest that the ongoing presence of Veillonella species in patients with UC may be associated with a persistently aberrant intestinal microbiota even in the presence of inflammation. 24 This study further characterised the differences in faecal microbiota across different colonic locations and found that both Klebsiella and Lactobacillus species were exclusive to a formed pouch and are not present pre-colectomy. 24 Further comparisons of faecal samples between a UC pouch and a UC ileostomy showed higher numbers of Bacteroides spp., Bifidobacteria spp. 23 and Enterococci spp. 22 in the UC pouch ( Tables 1   and 2 ).
| Summary
Colonic bacteria are found in the ileostomy and continue to predominate in the ileoanal pouch. Following ileostomy closure, anaerobic bacteria appear to be more prevalent in the ileoanal pouch. Biopsy samples showed higher levels of Proteobacteria belonging to Comamonadaceae, Moraxellaceae and Alcaligenaceae. 26 Faecal samples showed higher levels of Enterococcaceae and Clostridia spp. 22 (Table 4) .
Consistent findings in an un-inflamed UC ileoanal pouch compared with an un-inflamed FAP pouch include higher levels of Proteobacteria and lower levels of Bacteroidetes.
| Microbiota in acute pouchitis
Similar to IBD, bacterial diversity has been shown to be reduced in patients with pouchitis 21, 24, [31] [32] [33] with changes in both anaerobic and aerobic bacteria noted. 34 Analysis of faecal samples has shown higher levels of aerobes and lower levels of anaerobes in patients Proteobacteria 66.6% vs 29.5% (P = .019) Comamonadaceae 5% vs 0% (P = .007) Moraxellaceae 15% vs 0% (P = .027) Alcaligenaceae 5% vs 2% (P = .03) Bacteroidetes 0% vs 30% (P = .001) Firmicutes family 20% vs 40% (P = .007)
No raw data.
usual commensals of the ileoanal pouch and are found in soil and water 40 and therefore must be interpreted with caution.
| Summary
In acute pouchitis overall bacterial diversity is reduced. The consistent finding in acute pouchitis across studies is an increase in Clostridium species with more robust studies demonstrating a decrease in Enterococcaceae.
| Chronic pouchitis
Chronic pouchitis defined by the Heidelberg pouchitis activity score 41 or the need for long-term medications to control between an inflamed and non-inflamed pouch, they found reductions in both Streptococcus spp. and Clostridium spp. in chronic pouchitis. 28 
| Summary
Chronic pouchitis has been linked with an increase S. aureus. In comparison with acute pouchitis, reductions in Clostridium species are a consistent finding in chronic pouchitis. As has been seen in ileal
Crohn's disease, F. prausnitzii is reduced in chronic pouchitis.
| Longitudinal changes in microbiota in the pouch
The microbiota of the ileoanal pouch has been shown to evolve over both the short term and long term in a manner that is unique to each (Table 7) individual. 44 Early microbiota changes have been demonstrated within 2 months of restoration of intestinal continuity, with colon-predominant anaerobic bacteria present in higher proportions in faecal samples, alongside a decrease in numbers of ileumpredominant species. 45 The most prevalent bacterial species found in faecal samples of the ileoanal pouch were Veillonella (90%), Enterobacter (70%), Klebsiella (70%), Staphylococcus (60%), Corynebacterium (60%), Peptococcus (60%), Clostridium (50%) and Lactobacillus (50%). 24 Of these, Enterobacter spp. showed the highest mean concentration. 24 Almeida et al 24 compared faecal samples from the rectum pre-surgery and from patients with an ileoanal pouch 2 months post-surgery. They found Staphylococcus spp. and Corynebacterium spp. were found in less abundance (40% vs 70%) and (30% vs 60%) respectively, with increases in abundance of Bacteroidetes (30% vs 20%; P = .049), Lactobacillus spp. (30% vs 0%; P = .004) and Veillonella spp. (90% vs 30%; P = .035). 24 When the faecal microbiota of UC ileoanal pouch patients at 2 months after ileostomy closure was compared with the terminal ileum of healthy volunteer controls, Enterobacter spp. and Klebsiella spp., were significantly more prevalent whereas Enterococcus spp.
and Staphylococcus spp. were more prevalent in controls. 24 There were decreases in the anaerobic bacteria Clostridium coccoides,
24
Clostridium leptum subgroups, the Bacteroides fragilis group, and also in Atopobium spp. 45 when comparing their prevalence in faecal samples prior to colectomy and after closure of the loop ileostomy. By 6 to 12-months after closure of the ileostomy, the prevalent species present in faecal samples from the ileoanal pouch were E. coli, Veillonella spp., Enterobacter spp., Klebsiella spp. and Peptococcus spp. 24, 41 . Of these, E. coli and Enterobacter spp. had the highest mean concentration. 24 The authors of this study concluded that the microbiota composition found prior to ileoanal pouch surgery for UC patients was similar to the composition found in the healthy ileoanal pouch after both 2 and 8 months, following ileostomy closure. This suggests that the non-inflamed ileoanal pouch tended to recover to a microbial composition similar to pre-surgery values. 24 Studies looking at the faecal microbial diversity 1 year following ileostomy closure have shown that the microbiota composition had stabilised to reflect a more colonic profile. 25, 45 This is supported by the decrease in Lactobacillus spp. and Enterococcus spp., which predominate in the small bowel microbiota. 45 
| Summary
The ileoanal pouch microbiota transforms from a microbiota profile typically found in the small bowel to a more "colonic" microbiota over-time with both Enterococcus spp. and Lactobacillus spp. Clostridium paraputrificum 0% vs 8% total composition Escherichia coli/Shigella spp. 11% vs 18% total composition Streptococcus spp. 0% vs 34% total composition reducing in numbers over-time. These changes can occur as early as 2 months, with more stability in the microbiota noted with increasing age of the ileoanal pouch.
T A B L E 6 Microbiota in chronic pouchitis
| Prevention and predictors of pouchitis
In analysis of faeces from patients with UC prior to ileoanal pouch formation, it has been seen that that a predominance of Ruminococcus gnavus, Bacteroides vulgatus and C. perfringens and absence of Blautia spp. and Roseburia spp. can be predictive of pouchitis. 47 This was the first study to suggest that certain patterns in the microbiota can predict those who get pouchitis and those that do not. It will be important to repeat this study with larger numbers to potentially find patterns in the microbiota that predict those that may develop disease. This may help pre-operative counselling for a patient, whilst also giving a potential opportunity to alter the gut microbiota to prevent future complications with the ileoanal pouch.
| Microbiota changes following treatment of pouchitis with antibiotics
The mainstay of pouchitis treatment is antibiotics. It is yet not fully understood the influence these have on disease course (Table 8) .
Interestingly, Tannock et al 43 found that antibiotic administration (either ciprofloxacin, ceftin, cefuroxime or metronidazole) did not reduce the total number of bacteria in faecal ileoanal pouch samples. 43 In contrast, Kuhbacher et al, 48 found that antibiotic use in pouchitis was associated with a lower bacterial richness and diversity in biopsies from patients who achieved remission. 48 When comparing faecal samples from pouchitis patients who were using antibiotics with those not doing so, it was found that those not taking antibiotics had fewer Firmicutes and higher numbers of Proteobacteria. 43 In faecal samples from patients taking maintenance antibiotics for chronic pouchitis, Caulobacteriaceae, Sphingomonadaceae, Comamonadaceae, Peptostreptococcaceae, were significantly reduced. 43 With regard to the microbial impact of specific antibiotics, it has been shown that treatment with metronidazole resulted in complete eradication of anaerobic bacteria including C. perfringens. 32 When pouchitis patients were treated with ciprofloxacin, C. perfringens and all coliforms including haemolytic strains of E. coli disappeared. 32 Both ciprofloxacin and metronidazole are the first line treatments for pouchitis 49 and result in clinical remission in about 60% of patients. 49 As both C. perfringens and E. coli have been associated with pouchitis, 32, 33 this gives further credence to the concept that manipulating the gut microbiota to alter specific bacteria may help prevent this disease.
| Summary
Antibiotic treatment for pouchitis is associated with an overall reduction in bacterial richness within the ileoanal pouch. Reduction in both E. coli and Clostridia species appears to be important in treating pouchitis but this requires further clarification. 50 However, it has been shown that microbiota alterations after probiotic treatment were not sustained long term. 31 Kuhbacher et al 48 suggested that it was the increase in microbial diversity/richness that was responsible for maintenance of remission. 48 In a study using a different probiotic (MIYA-BM), it was found that treatment resulted in a reduction in Escherichia spp. and Bifidobacterium spp. in faecal samples. 
| DISCUSSION
This review has highlighted that undoubtedly the microbiota plays an important role in both the inflamed and the healthy ileoanal pouch with evidence suggesting that it may have a larger role in gut health. 52 Overtime, the pouch microbiota transforms into a more "colonic" typical phenotype after ileostomy closure. Similar to findings in IBD, a decrease in bacterial diversity and dysbiosis are associated with both acute and chronic inflammation. Changes in Clostridium spp. and E. coli have been shown to be associated with inflamed pouches, non-inflamed pouches and treatment response.
Inconsistent findings across studies mean that it is difficult to assign a causative relationship of these changes with these phenomena.
There are many studies that highlight changes in bacterial com- An important consideration, is understanding if the inflammatory process causes the change in the microbiota, or vice versa. Studies have shown that certain microbiota can predict the development of pouchitis, suggesting that it may be that these bacteria are present prior to the onset of inflammation. 47 Interestingly, bacterial populations change over time with some signature changes being present in both inflamed and in non-inflamed tissue. Additional studies are needed to characterise the functional significance of these changes.
Furthermore, in the inflammatory process, it may be that alterations in bacterial metabolic capabilities are more important than individual bacterial changes. Therefore, looking at functionality of the ensuing microbiota rather than trying to define the community composition 18 and the microbiota is just one of the factors that contribute to inflammation. This is obviously an issue with any disease and is something that cannot be avoided but should be considered when analysing the literature. This review has highlighted the heterogeneity of the gut microbiota between different patient populations. Given the relatively small numbers in each study, there is a need for a larger, more definitive study.
With advancing techniques in metagenomics, metaproteomics and metatranscriptomics, we may be able to better understand the role of the microbiota in a ileoanal pouch both in health and disease.
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